Robert R. Conley | Psychiatrist.com

Article

Adverse Events Related to Olanzapine

Original Research

Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone

Article

The Application of Neuroimaging Techniques to Drug Development

Original Research

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study

Original Research

Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000

Original Research

A Dose-Outcome Analysis of Risperidone

Article

Evaluating Clinical Trial Data: Outcome Measures

Academic Highlights

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

Article

Optimizing Treatment With Clozapine

Letter to the Editor

Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

Original Research

Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia

Original Research

Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study

Article

Risperidone Side Effects

Letter to the Editor

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update

Original Research

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia